Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases

Zitta Barrella Harboe; Sebastian Rask Hamm; Laura Pérez-Alós; Pradeesh Sivapalan; Helene Priemé; Torgny Wilcke; Peter Kjeldgaard; Saher Shaker; Alexander Svorre Jordan; Dina Leth Møller; Line Dam Heftdal; Johannes Roth Madsen; Rafael Bayarri-Olmos; Cecilie Bo Hansen; Mia Marie Pries-Heje; Rasmus Bo Hasselbalch; Kamille Fogh; Jose Juan Almagro Armenteros; Linda Hilsted; Erik Sørensen; Birgitte Lindegaard; Andrea Browatzki; Tor Biering-Sørensen; Ruth Frikke-Schmidt; Sisse Rye Ostrowski; Kasper Karmark Iversen; Henning Bundgaard; Susanne Dam Nielsen; Peter Garred; Jens-Ulrik Stæhr Jensen

doi:10.1136/bmjresp-2022-001268

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

PDF

Respiratory infection

Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password